MedTrace Logo

Improving Mood in Assisted Living Settings

NCT01763216 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 351

Last updated 2020-11-09

No results posted yet for this study

Summary

Late-life depression levels are escalating, and include 24% of all tenants of Assisted Living (AL) settings. A promising, novel intervention is a computerized visual speed of processing training program known as Road Tour. Road Tour has been show to reduce depressive symptom levels and the risk of onset of clinical depression in community dwelling older adults. The investigators hypothesize that similar benefits will accrue to residents in AL settings.

To evaluate this the investigators will use a two-arm, parallel, randomized controlled trial (RCT) comparing Road Tour training to attention control using computerized crossword puzzles among 370 adults 55 years old or older who reside in 15-30 AL settings that are partnering with the investigators.

The investigators hypothesize that Road Tour participants will have improved cognitive processing speed, lower levels of depressive symptoms, lower likelihood of the onset of clinical depression, less anxiety, lower levels of pain symptoms, and better health-related quality of life. These outcomes will be assessed at baseline, post-training, six months, and one year.

Conditions

  • Depressive Symptoms
  • Clinical Depression

Interventions

OTHER

Road Tour

Training dosage includes 10 hours at baseline, four hours of booster training at month five, and four hours of booster training at month 11.

OTHER

Boatload of Crosswords

Training dosage includes 10 hours at baseline, four hours of booster training at month five, and four hours of booster training at month 11.

Sponsors & Collaborators

  • Marianne Smith

    lead OTHER

Principal Investigators

  • Marianne Smith, Ph.D. · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2016-11-30
Completion
2020-11-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01763216 on ClinicalTrials.gov